(Q36598962)

15 August 2017

title

EFNS guidelines on management of restless legs syndrome and periodic limb movement disorder in sleep (English)

1 reference

periodic limb movement disorder

15 August 2017

main subject

1 reference

based on heuristic

inferred from title

restless legs syndrome

1 reference

L Vignatelli

1

0 references

author name string

M Billiard

2

1 reference

15 August 2017

P Clarenbach

3

1 reference

15 August 2017

D Garcia-Borreguero

4

1 reference

15 August 2017

D Kaynak

5

1 reference

15 August 2017

V Liesiene

6

1 reference

15 August 2017

C Trenkwalder

7

1 reference

15 August 2017

P Montagna

8

1 reference

15 August 2017

EFNS Task Force

9

1 reference

15 August 2017

publication date

1 October 2006

1 reference

European Journal of Neurology

15 August 2017

published in

1 reference

15 August 2017

volume

13

1 reference

15 August 2017

issue

10

1 reference

15 August 2017

page(s)

1049-1065

1 reference

Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

Validation of the Restless Legs Syndrome Quality of Life Instrument (RLS-QLI): findings of a consortium of national experts and the RLS Foundation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

Treatment of periodic leg movement disorder and restless leg syndrome with talipexole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

Treatment of restless legs syndrome with gabapentin: a double-blind, cross-over study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

Treatment of idiopathic restless legs syndrome (RLS) with gabapentin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

Gabapentin versus Ropinirole in the Treatment of Idiopathic Restless Legs Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

Restless legs syndrome (RLS) and periodic limb movement disorder (PLMD): acute placebo-controlled sleep laboratory studies with clonazepam

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

Treatment of restless legs syndrome and periodic movements during sleep with L-dopa: a double-blind, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

A controlled study of additional sr-L-dopa in L-dopa-responsive restless legs syndrome with late-night symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

Treatment of restless legs syndrome with the dopamine agonist alpha-dihydroergocryptine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

A double-blind randomized crossover trial of bromocriptine and placebo in restless legs syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

Effective cabergoline treatment in idiopathic restless legs syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

Efficacy of pergolide in treatment of restless legs syndrome: the PEARLS Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

Pergolide: treatment of choice in restless legs syndrome (RLS) and nocturnal myoclonus syndrome (NMS). A double-blind randomized crossover trial of pergolide versus L-Dopa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

Effects of bromocriptine on periodic limb movements in human narcolepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

Ropinirole for restless legs syndrome: a placebo-controlled crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

Restless legs syndrome improved by pramipexole: a double-blind randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

Ropinirole as a treatment of restless legs syndrome in patients on chronic hemodialysis: an open randomized crossover trial versus levodopa sustained release

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

A randomized, double-blind placebo-controlled trial of iron in restless legs syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

The treatment of restless legs syndrome with intravenous iron dextran

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

Amantadine is beneficial in restless legs syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

A double-blind, placebo-controlled trial of intravenous iron dextran therapy in patients with ESRD and restless legs syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

Long-term course of restless legs syndrome in dialysis patients after kidney transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

Daytime sleepiness in patients with CRF: impact of nocturnal hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

Insomnia in depression: differences in objective and subjective sleep and awakening quality to normal controls and acute effects of trazodone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

Levodopa in restless legs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

Dopaminergic treatment of restless legs and rebound phenomenon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

Static mechanical hyperalgesia without dynamic tactile allodynia in patients with restless legs syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

Low-dose pramipexole in the management of restless legs syndrome. An open label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

A randomized controlled study of pergolide in patients with restless legs syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

Pergolide: treatment of choice in Restless Legs Syndrome (RLS) and Nocturnal Myoclonus Syndrome (NMS). Longterm follow up on pergolide. Short communication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

Randomized, double-blind, placebo-controlled trial of pergolide in restless legs syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

Long-term effects of pergolide in the treatment of restless legs syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

Ropinirole for restless legs syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

Sleep laboratory studies in restless legs syndrome patients as compared with normals and acute effects of ropinirole. 1. Findings on objective and subjective sleep and awakening quality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

Sleep laboratory studies in restless legs syndrome patients as compared with normals and acute effects of ropinirole. 2. Findings on periodic leg movements, arousals and respiratory variables.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

Encouraging initial response of restless legs syndrome to pramipexole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

Acute placebo-controlled sleep laboratory studies and clinical follow-up with pramipexole in restless legs syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

Gabapentin versus levodopa for the treatment of Restless Legs Syndrome in hemodialysis patients: an open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

Pramipexole for the treatment of uremic restless legs in patients undergoing hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

Valproate for sleep consolidation in periodic limb movement disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

The use of triazolam in older patients with periodic leg movements, fragmented sleep, and daytime sleepiness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

Comparison between dopaminergic agents and physical exercise as treatment for periodic limb movements in patients with spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

The effects of pramipexole in REM sleep behavior disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

Treatment of periodic limb movements in sleep with selegiline HCl.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

Effects of Short-Term Modified Fasting on Sleep Patterns and Daytime Vigilance in Non-Obese Subjects: Results of a Pilot Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

Familial restless legs with periodic movements in sleep: electrophysiologic, biochemical, and pharmacologic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

Long-term effect of dopaminergic drugs in restless legs. A 2-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

Pleuropulmonary disease due to pergolide use for restless legs syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

Restless legs syndrome augmentation and pramipexole treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

Worsening of autosomal dominant restless legs syndrome after use of mirtazapine: case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

Augmentation and tolerance with long-term pramipexole treatment of restless legs syndrome (RLS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

Response to opioids in three patients with restless legs syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

Long-term follow-up on restless legs syndrome patients treated with opioids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

Successful treatment of restless legs syndrome with an implanted pump for intrathecal drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

Dopaminergic therapy in children with restless legs/periodic limb movements in sleep and ADHD. Dopaminergic Therapy Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

Dopamine agonist treatment of Tourette disorder in children: results of an open-label trial of pergolide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

The effect of sclerotherapy on restless legs syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

Low body stores of iron and restless legs syndrome: a correctable cause of insomnia in adolescents and teenagers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

Pathological yawning (chasm) associated with periodic leg movements in sleep: cure by levodopa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

Extrapigmentary effects of melanocyte-stimulating hormone in amenorrhoeic women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

Incidence of periodic leg movements and of the restless legs syndrome during sleep following acute physical activity in spinal cord injury subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01410.X

10.1111/J.1468-1331.2006.01410.X

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference